arginyl-glycyl-aspartic acid has been researched along with Acquired Immune Deficiency Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barillari, G; Ensoli, B; Gallo, RC; Gendelman, R | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.
Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Antibodies; Cell Adhesion; Cells, Cultured; Culture Media, Conditioned; Endothelium, Vascular; Gene Products, tat; HIV-1; Humans; Integrins; Lymphocyte Activation; Molecular Sequence Data; Muscle, Smooth, Vascular; Oligopeptides; Peptide Fragments; Receptors, Cytoadhesin; Receptors, Fibronectin; Receptors, Vitronectin; Recombinant Proteins; Sarcoma, Kaposi; T-Lymphocytes; tat Gene Products, Human Immunodeficiency Virus | 1993 |